TMBS E120: Sean Flovenski BIO IQ Testing & COVID-19

Start listening

BIO IQ UPENDING TESTING INDUSTRY AMID COVID-19 Modernizing Testing to Keep Workforces and Communities Safe. 

The U.S. isn’t doing enough testing to control COVID-19. according to researchers at Harvard Global Health Institute who say we need 4.4 million tests per day to reach “a basic level of proactive testing,” and far more (14M) is necessary to safely reopen the economy. Yet, we’ve never managed to perform more than 1M per day. Not to mention the COVID confusion, misinformation, and the fact that too often consumers are getting unreliable or outdated test results – rendering them useless.  Sean Slovenski is recognized as a healthcare industry innovator with 30 years of success. [Text Wrapping Break]As former SVP and President of Walmart Health, Sean led the launch of multi-disciplinary healthcare clinics known as the Super Centers for Healthcare.” [Text Wrapping Break][Text Wrapping Break]Today, Sean serves as the CEO of BioIQ – a company modernizing the diagnostic testing industry through a national network of labs and customized solutions that support health plans, employers, and consumers.[Text Wrapping Break][Text Wrapping Break]By aggregating testing solutions, optimizing lab capacity, and integrating testing with customers’ needs and strategies, BioIQ helps ensure stability and resilience for employers and health plans by detecting disease to protect their workforces and members.
Join the discussion